NCT05310734 - PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age With Scabies | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 4, 2022

Primary Completion Date

November 30, 2025

Study Completion Date

March 31, 2026

Conditions

Scabies

Interventions

DRUG

Spinosad Topical

A topical suspension indicated for the treatment of scabies is used for this PK and Safety Study

Trial Locations (3)

RECRUITING

L&C Professional Medical Research Institute, Miami

RECRUITING

Velocity Clinical Research, Lafayette

RECRUITING

Elixir Research Group, Houston